For those trying to think about the effect of their lifestyle on the environment, traveling responsibly can be difficult, especially if you don't speak the language or know the culture of your destination. While there are more and more movements towards sustainability in Japan, convenience is still something that is made a priority in big cities like Tokyo, which can mean a lot of plastic, paper, and other sorts of waste. And many of those conveniences are put in place to make things easier for tourists as well. But if you want to travel responsibly, there are some small changes you can make during your time in Japan to reduce the amount you consume.
Culturally, wrapping is an important practice. When giving someone a gift, or handing a customer a purchased item, having taken the time to carefully package an item and make it presentable is incredibly important. Traditional wrapping itself is incredibly eco-friendly! Furoshiki, square cotton cloths, used to be a common covering that was artfully tied around gifts.
Nowadays, you'll see that paper and plastic bags abound. If you make a small purchase at a convenience store, unless you specifically ask the clerk not to, they will immediately put your purchase in a plastic bag. Memorize one of these simple Japanese phrases, or let's be real, you can also communicate this in English or by taking a screenshot to tell your clerk you don't need a bag.
EX 2: I don't need a bag!
If you make multiple purchases on a day out shopping, you can also ask for your items to be placed in a bag you already received.
EX 3: Do you mind consolidating my things into one bag?
Matomete onaji fukuro ni irete itadaite ii desuka?
Okay, this one is a mouthful for people who aren't keen on learning Japanese…. But gestures are also a great way of showing staff you want your things together.
This is a great chance to get a nice souvenir while reducing your paper waste. People in Japan still bring handkerchiefs with them on a daily basis. This is super handy for the hot and humid summer months when you might need to wipe the perspiration from your face before an important meeting. It's also common to have small towel handkerchiefs for use in public restrooms in lieu of one-time use paper towels. This is a big recommendation not only for your time in Japan, but also as a good habit to consider bringing back home! In addition to being a fun buy and a great gift, these handkerchiefs can literally be found everywhere, from small neighborhood shopping streets to department stores. Handkerchiefs come in infinite colors and designs, so plenty of options.
When travelling, a lot of people opt for the "I can buy it when I get there mindset." And for several things, this is true. However, this way of thinking can also lead to a lot of waste. Purchasing shampoo in hard plastic bottles only to throw them out half full might be something people expect of travel, but it's not very eco-friendly. We suggest if you want to purchase toiletries after landing, that you go to a store that offers travel goods that you can use time and time again. One of Japan's most popular shops, Mujirushi, has a huge selection of travel goods that can be bought at a low price and used time and time again. And if you don't want to carry around your toiletries, purchasing samples is a good way to avoid wasting things you didn't get the chance to use and throwing out reusable plastics. It also doesn't hurt to check and see if your hotel or AirBnB offers free soaps. In that case, the best way to avoid waste is to simply use the freebies.
And finally, many hostels have a 'Leave Something Take Something' basket in the shared area. In the cast that you overbuy, consider leaving the rest for someone else.
We know exploring the novelty of vending machines in Japan is something special. They offer unique seasonal drinks you can only find here, from hot canned coffee to fizzy drinks with jelly. And we totally understand, who would want to pass these up! It's alright to have a treat once in a while, but being selective and keeping track of how many things you purchase can help you reduce the amount of plastic bottles you consume. If you want to try specialty drinks, then consider not purchasing bottled water. Coming to Japan with a lightweight canteen/reusable bottle will really come in handy. In places like Tokyo, tap water is drinkable, so we recommend filling up your bottle at the beginning of each day. Not only is this good for the environment, but it will help your budget as well, as a 500ml bottle of water will on average cost between 100 and 130 JPY.
5. Separate your trash at home!
When travelling to Japan for the first time, some people are surprised by the lack of public trash cans.
Where do people throw their trash?
When on the go, if you have garbage there's a simple courtesy that people here abide by: bring your trash home. Sometimes, especially if people are out for an entire day or going for a hike or some similar activity, they'll carry a small bag just for garbage with them. Recently, you'll see that most convenience stores have garbage cans meant for customers who either eat at the eat-in spaces, or outside the entrance. If you have a lot of plastic trash, it might seem like a good shortcut to sneak a bag into a convenience store garbage bin, but taking your trash back to your accommodation and separating it for recycling is the more responsible route.
Finally, this is a pretty big one when it comes to travel! Most people look to stay connected during their travels, and pre-paid SIMs have become increasingly popular. The downside to these popular cards that make it easy to connect literally anywhere in the world (oftentimes for a low price) is that there is so much waste involved. Just look at the card above. For a thumbnail-sized SIM, a credit card sized piece of hard plastic is often used in packaging. The SIM card itself is made of a combination of ingredients including silicon, plastic, and metals such as aluminium, copper, and a thin outer layer of GOLD. So yes, when you toss a SIM Card, you are throwing some 24K in the trash! Instead of purchasing prepaid SIMs, consider using a SIM Rental or WIFI Rental. There are several, providers out there, but we can suggest out partner, CDJapan Rental for low prices and great customer service.
So is environmental responsibility something you consider when you you travel? How do you reduce your footprint?
I know this is an older post but I a traveler too setting up a new blog and its been very helpful! Thank you for sharing..


text:
We Didn't Start the Fire – Lesson Plan
In 1989, Billy Joel released the song We Didn't Start the Fire. I created a lesson sequence in which students analyse the song's interpretations of the past, and and wrote an article about it in December 2009's edition of Teaching History for the Historical Association. The learning really comes in when we consider why Billy Joel decided to include the events that he did. You can read my sequence overview below, or you can click to download the full We Didn't Start the Fire article, in which I also discuss how the lesson sequence has been implemented in the UK and Egypt.
In order to teach the sequence outlined below, you will firstly need a copy of the music video I produced for the song, which you can download here.
Introduce song and its events. Students choose an event and begin to research it (check out www.teacheroz.com/fire.htm as a great starting point) – focus on significance. Give an overview of the event/person/etc. but also think about why Billy Joel chose to include it. What was special/significant about it? Students to prepare a presentation to present next week.
Finish presentation preparation and watch. As students present their findings, brainstorm the different definitions of what makes an event significant. Discuss the range of possible explanations for what makes something "significant".
Brainstorm events/people/developments of the years since the song was released (1989 onwards). Discuss which of these are significant and why – link back to the definitions of significance from last week. Do different people have different ideas of what is significant in our lifetime? In pairs/small groups students to look at their significant events and write their own verse for "We Didn't Start the Fire". You may find the syllable grid a useful resource to give to students to help them with this activity. As annoying as it is to hear the song over and over again, the students usually like to have the song played on repeat so they can practise their lyrics. Click here for a karaoke version you could use.
Students to use Audacity (freeware audio software) to record them singing their own verse over the karaoke track. When this is complete, students should export the finished MP3 file to Windows Movie Maker and use Google Images to find pictures to create a video to accompany their song.
The completed videos are perfect examples of ICT being used to access high quality historical thinking skills. "Significance" is often a challenging key element to plan for, but I hope this overview helps you to include it in a lesson sequence.
For details of the full lesson sequence, download the article here.
We Didn't Start the Fire – Video Download
GCSE and IGCSE History Revision, Videos, International Relations Since 1945, We Didn't Start the Fire
Many people have created videos to accompany the song, but I felt that I should have a go at developing my own. The version of this video I placed on TeacherTube is in the Top 10 most viewed videos of all time and has received over 900,000 views. You can watch it in the video player below or can download a high resolution version to save to your computer:
We Didn't Start the Fire – Syllable Grid
Other History Topics, We Didn't Start the Fire
The third stage of the We Didn't Start the Fire the lesson sequence requires students to write an updated verse for the song. Some students struggle with the division of syllables and beats, so I devised this simple grid to help them structure their verses to fit the original song pattern. The original lyrics follow a particular song structure and so, by having a visual reference that demonstrates how the lyrics were made to fit the verse, students may find it easier to make their own versions fit with the original.
Download here – We Didn't Start the Fire – Syllable grid for lyrics (portrait version)
We Didn't Start the Fire – Backing Track
The third part of the We Didn't Start the Fire lesson sequence involves students writing their own verse to 'update' the song. As annoying as it is to hear the song over and over again, the students usually like to have the song played on repeat so they can practise their lyrics. The media file below is a karaoke version of the song that you could play.
http://www.mrallsophistory.com/revision/wp-content/uploads/2012/11/We-Didnt-Start-the-Fire-backing-track.mp3
Abyssinia Battle of Bosworth Catholicism Communism constitution Czechoslovakia Display Edward II English Civil War Europe exam exam skills execution France Freikorps gas Haig History Teacher Hitler James II Judaism Kaiser Wilhelm I Lady Jane Grey Lloyd George Magna Carta Manchuria Medici monarchy Nuclear Papal States Paris peace treaties Philip IV railways Rome Saddam Hussein Saladin Scotland SS superstition taxes Treaty of Vienna Varennes Wall Street Crash Zollverein

redpajama_set_name: RedPajamaCommonCrawl


text:
Edward P. Djerejian
"Ambassador Djerejian is the founding Director of the James A. Baker III Institute for Public Policy at Rice University. His career in public service has spanned the administrations of U.S. Presidents Ronald Reagan, George H.W. Bush and William J. Clinton. During the Reagan Administration, he served as Deputy Assistant Secretary of Near Eastern and South Asian Affairs, as Deputy Chief of the U.S. mission to the Kingdom of Jordan and as Special Assistant to the President and Deputy Press Secretary for Foreign Affairs in the White House. He served as the U.S. Ambassador to the Syrian Arab Republic from 1988 to 1991 under Presidents Reagan and Bush, and then served Presidents Bush and Clinton as Assistant Secretary of State for Near Eastern affairs from 1991 to 1993. President Clinton named him U.S. Ambassador to Israel in 1993. Ambassador Djerejian was a Senior Advisor to the Iraq Study Group, a bipartisan panel mandated by the Congress to assess the current and prospective situation in Iraq in 2006. Ambassador Djerejian is a director of Baker Hughes, Inc., where he is a member of the governance and compensation committees, and Global Industries, Ltd, where he is Chairman of the Governance Committee.
"Qualifications: Ambassador Djerejian is a leading expert on the complex political, security, economic, religious and ethnic issues of the Middle East. His experience brings valuable insight that enhances the Board's ability to assess operations and business opportunities in the company's important Middle East/North Africa region. Throughout his career, he has developed an in-depth knowledge of the political and economic landscape in the United States and in the Middle East, and expertise in foreign policy, geopolitics of energy and corporate governance. He serves on several public and nonprofit boards." [1]
National Advisory Council, U.S. Interreligious Committee for Peace in the Middle East
Trustee, Eurasia Foundation
Honorary Trustee, Physicians for Peace
Director, Occidental Petroleum
Chair, Advisory Group on Public Diplomacy for the Arab and Muslim World [2]
Resources and articles
Related Sourcewatch
↑ Directors, Occidental Petroleum, accessed May 13, 2010.
↑ New Strategic Direction Urged for Public Diplomacy, iwar.org.uk, accessed January 21, 2011.
Retrieved from "https://www.sourcewatch.org/index.php?title=Edward_P._Djerejian&oldid=507989"


text:
A Levina a Levin férfinév női párja.

Gyakorisága
Az 1990-es években és a 2000-es években  nem lehetett anyakönyvezni.

Névnapok
 nincs hivatalos

Híres Levinák

Jegyzetek

Magyar keresztnevek (L)
Női keresztnevek (L)
Német eredetű magyar női keresztnevek

redpajama_set_name: RedPajamaWikipedia


text:
International Journal of Dentistry
International Journal of Dentistry / 2011 / Article
AbstractIntroductionResultsDiscussionConclusionReferencesCopyright
Kubilay Isik, Abdullah Kalayci, Ercan Durmus, "Comparison of Depth of Anesthesia in Different Parts of Maxilla When Only Buccal Anesthesia Was Done for Maxillary Teeth Extraction", International Journal of Dentistry, vol. 2011, Article ID 575874, 3 pages, 2011. https://doi.org/10.1155/2011/575874
Comparison of Depth of Anesthesia in Different Parts of Maxilla When Only Buccal Anesthesia Was Done for Maxillary Teeth Extraction
Kubilay Isik,1,2 Abdullah Kalayci,3 and Ercan Durmus3
1Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, 06490, Ankara, Turkey
2Baskent Universitesi Konya Uygulama ve Arastirma Merkezi, Konya, Turkey
3Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Selcuk University, 42079, Konya, Turkey
Academic Editor: Daniel M. Laskin
Received07 Jul 2011
Accepted01 Aug 2011
Published22 Sep 2011
Objective. Recently, some authors reported that maxillary teeth could be extracted without using palatal anesthesia, but they did not clearly specify the extracted teeth. This is important, because apparently the local anesthetic solution infiltrates the maxilla and achieves a sufficient anesthesia in the palatal side. Thus, thickness of the bone may affect the depth of anesthesia. The aim of this study was to compare the depth of anesthesia in different parts of the maxilla when only a buccal infiltration anesthesia was done. Patients and Method. The maxilla was divided into anterior, premolar, and molar regions. In each region, 15 teeth were extracted with a single buccal infiltration. The patient marked the pain level on a numerical rating scale. Results. Anesthesia depth was sufficient and was not significantly different ( ) among three maxillary regions. Conclusion. Except for surgical interventions, all maxillary teeth can be extracted using only a buccal infiltration anesthesia.
The use of palatal anesthesia (PA) is a well-known procedure, and it has been described in detail in textbooks. Since it is a rather painful injection [1], some techniques such as pressure [2], electronic [3], cryogenic [4], or topical anesthesia [5] have been suggested to reduce the patient's discomfort. However, those methods are not universally effective, and PA remains a painful experience for most patients [6].
Recently, it has been claimed that maxillary permanent teeth could be extracted without PA [6, 7]. In those reports, although the indications of extractions were listed, it was not clear which teeth were removed. This is important, because apparently the success of the technique depends on diffusion of any local anesthetic from vestibular side to palatal side [8]. Thus, it can be claimed that while that distance increases, diffusion ability of the local anesthetic to the palatal side will decrease. In other words, a single buccal infiltration anesthesia without PA may be sufficient in anterior maxilla, where the buccopalatal distance is shorter, but it may be not suitable for molar teeth, where buccopalatal distance is longer.
The aim of this study was to investigate if the depth of anesthesia was adequate in all parts of maxilla when only a buccal infiltration anesthesia was done for maxillary permanent teeth extractions.
2. Patients and Method
The study was approved by the Ethical Committee of the Baskent University Clinical Researches. Forty-five patients aging between 15 and 76 were included to the study, and one tooth was extracted from each patient. Pediatric patients, the patients who were allergic to Articain and the teeth that needed surgical procedures were excluded.
The maxilla was divided into three regions, and 15 teeth were extracted from each region as follows:(i)anterior: central, lateral, and canine teeth,(ii)premolar: first and second premolars,(iii)molar: first and second molars.
2 mL of local anesthetic solution containing 80 mg Articain HCl and 0.012 mg epinephrine was used (Ultracain D-S, Sanofi-Aventis, Istanbul, Turkey). 1.7 mL of the solution was injected according to conventional methods [9] (Figure 1). The remaining 0.3 mL of the solution was left to use for PA if the patient would have a pain during the extraction. All teeth were anesthetized with a single buccal injection. Infraorbital anesthesia or posterior alveolar nerve blocks were not employed.
Technique of buccal infiltration anesthesia.
After waiting five minutes, as suggested by Uckan et al. [7], the numbness of the palatal mucosa was gently checked with a dental probe and the patient asked if it was painful. The patient was told to warn us if he would have felt a moderate or severe pain during the extraction. Then, the tooth was slowly extracted in usual way. The patient was also asked to mark the extraction pain on an 11-point numerical rating scale (between 0 and 10) anchored with the expressions "no pain" and "the worst pain imaginable" on its ends.
The pain scores were statistically analyzed with the Kruskal Wallis test by using a commercial software (SigmaStat v3.5, SysStat Software, Richmond, Calif, USA). Statistical significance was accepted at 95% confidence level.
All patients tolerated the extractions well, and none of them reported severe pain. All patients verbally described the procedure "totally painless" or "a very slight discomfort" (Table 1). Statistical analysis revealed that there were no significant difference among three maxillary regions ( ). The palatal mucosa probing was slightly or moderately painful in all patients. Since the aim of this study was to evaluate only the extraction procedure, no statistical analysis was performed for palatal mucosa probing results.
Anterior Premolar Molar
Pain scores that were obtained during teeth extractions from three different maxillary regions.
Palatal injection for permanent maxillary tooth removal is poorly tolerated by the patients, and it is one of the most painful procedures in dentistry [10, 11]. Piercing the mucosa is painful to a degree, but the main source of the pain is displacement of the mucoperiosteum [12]. To overcome this, many techniques have been suggested [2–5], but none of them is universally effective, and some of them even require specific equipment [13].
Recently some authors reported that maxillary erupted the third molars, and other permanent teeth could be extracted by using only buccal infiltration anesthesia [6, 7, 14]. There are three opinions explaining the efficiency of the technique. First, it has been advocated that the anesthetic requirement for tooth extraction is not as high as that required for routine conservative dental treatment [15]. Second, it has been claimed that Articaine diffuses more readily through soft and hard tissues than other local anesthetics [7]. Finally, it has been suggested that the porous nature of the maxilla facilitates the diffusion of any local anesthetic [8].
All of those opinions may be true and valid, but infiltration of the local anesthetic solution to the palatal side should be the most determinative factor. That also makes the distance between the buccal and palatal side of the maxillary alveolus important. Because it is obvious that diffusion of the solution to the palatal side will not be the same in a thicker alveolus. The authors who performed the technique and reported successful results [6, 7] listed the indications for the extractions (wisdom teeth, orthodontic teeth, fractured teeth, profound caries, periodontitis, etc.) and even reported a success rate according to indications (orthodontic treatment > periodontitis > prophylactic extraction > apical lesion > profound caries) [7]. However, in those reports, it was not clear which teeth were extracted. The goal of this study was to classify the maxillary teeth according to buccopalatal alveolar ridge thickness and to find if the technique is effective in all parts of the maxillary alveolus.
While, according to classical knowledge, 2-3 minutes will be sufficient in buccal infiltration anesthesia [9], a prolonged delay is necessary in this technique to allow diffusion of the solution to the palatal side. All of the patients described the extraction "completely painless" or a "very slight, faint pain," and there was no significant difference among three maxillary regions. However, it should be noted that all of the patients reported a considerable pain when probing the palatinal mucosa. Therefore, extraction of maxillary teeth without using PA is not suitable for surgical extractions or for the procedures in which the palatal mucosa will be manipulated by elevators or will be sutured.
The technique should be effective in pediatric patients, whose alveolar ridges are narrower than adults, as well. However, pediatric patients were not included to the study because they might not express the pain correctly. Upper third molars were also not included to the study, but it has already been demonstrated that the technique is successful for erupted upper third molars [14].
After an enough delay, it is possible to extract the maxillary teeth without PA and the technique is effective for all maxillary teeth. However, PA, is a must for the teeth requiring surgical procedures.
B. F. McArdle, "Painless palatal anesthesia," Journal of the American Dental Association, vol. 128, no. 5, p. 647, 1997. View at: Google Scholar
J. Kravitz, "The palatal press and roll anesthesia technique," Practical Procedures & Aesthetic Dentistry, vol. 18, no. 4, pp. 242–245, 2006. View at: Google Scholar
J. G. Meechan and R. A. Winter, "A comparison of topical anaesthesia and electronic nerve stimulation for reducing the pain of intra-oral injections," British Dental Journal, vol. 181, no. 9, pp. 333–335, 1996. View at: Google Scholar
J. D. Duncan, G. W. Reeves, and J. G. Fitchie, "Technique to diminish discomfort from the palatal injection," The Journal of Prosthetic Dentistry, vol. 67, no. 6, pp. 901–902, 1992. View at: Google Scholar
J. G. Meechan, "Effective topical anesthetic agents and techniques," Dental Clinics of North America, vol. 46, no. 4, pp. 759–766, 2002. View at: Google Scholar
S. Fan, W.-l. Chen, Z.-H. Yang, and Z.-Q. Huang, "Comparison of the efficiencies of permanent maxillary tooth removal performed with single buccal infiltration versus routine buccal and palatal injection," Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 107, no. 3, pp. 359–363, 2009. View at: Publisher Site | Google Scholar
S. Uckan, E. Dayangac, and K. Araz, "Is permanent maxillary tooth removal without palatal injection possible?" Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 102, pp. 733–735, 2006. View at: Google Scholar
P. W. Shields, "Local anaesthesia and applied anatomy," Australian Dental Journal, vol. 31, no. 5, pp. 319–325, 1986. View at: Google Scholar
S. F. Malamed, Ed., Handbook of Local Anesthesia, Mosby-Year Book, Philadelphia, Pa, USA, 4th edition, 1997.
M. Frazer, "Contributing factors and symptoms of stress in dental practice," British Dental Journal, vol. 173, no. 3, p. 111, 1992. View at: Publisher Site | Google Scholar
P. Milgrom, S. E. Coldwell, T. Getz, P. Weinstein, and D. S. Ramsay, "Four dimensions of fear of dental injections," Journal of the American Dental Association, vol. 128, no. 6, pp. 756–762, 1997. View at: Google Scholar
T. Harker, "What injection?" British Dental Journal, vol. 182, no. 2, p. 50, 1997. View at: Google Scholar
F. Quarnstrom, "Electronic dental anesthesia," Anesthesia Progress, vol. 39, no. 4-5, pp. 162–177, 1992. View at: Google Scholar
M. E. Badcock, I. Gordon, and M. J. McCullough, "A blinded randomized controlled trial comparing lignocaine and placebo administration to the palate for removal of maxillary third molars," International Journal of Oral and Maxillofacial Surgery, vol. 36, no. 12, pp. 1177–1182, 2007. View at: Publisher Site | Google Scholar
D. H. Roberts and J. H. Sowray, Eds., Local Analgesia in Dentistry, Wright, Bristol, UK, 3rd edition, 1987.
Copyright © 2011 Kubilay Isik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Discussion in 'Apple Music, Apple Pay, iCloud, Apple Services' started by burmguy, Oct 14, 2011.
So I can either backup to itunes on PC or to the cloud?
Im a little confused. If I save to cloud it saves my contacts and email and the rest will sync with itunes (music and Apps) or what?
Edit: The iTunes Match part is related to the automatic download feature. Upload/download via mobile device or any computer using my home sharing library and get it anywhere. Also applies to ripped CDs.


text:
Home Features CDMOs and CMOs: A M&A and Expansion RoundupByPatricia Van Arnum
CDMOs and CMOs: A M&A and Expansion Roundup
Mixed Performance for the Global Biotech Industry
This year thus far has seen several high-profile deals in the pharmaceutical outsourcing market. So what moves should be on your radar?
There have been several noteworthy moves for contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) thus far in 2017: Thermo Fisher's pending $7.2-billion acquisition of Patheon, Lonza's $5.5-billion acquisition of Capsugel, and AMRI's pending acquisition by private-equity firms. So what other moves and expansions are making the mark thus far in 2017?
A roundup of activity: mergers and acquisitions
Thermo Fisher's pending $7.2-billion acquisition of Patheon. In the pharmaceutical outsourcing market, the largest deal thus far in 2017 is Thermo Fisher Scientific's pending $7.2-billion acquisition of Patheon, a CDMO of active pharmaceutical ingredients (APIs) and drug products. Thermo Fisher announced the acquisition in May 2017 with the deal expected to close by the end of 2017.
The acquisition of Patheon provides Thermo Fisher with small- and large-molecule development and manufacturing capabilities as well as formulation development and drug-product manufacturing. Thermo Fisher's products and services support research, clinical trials, and production and includes clinical trials logistics services. Patheon, which has approximately 9,000 employees worldwide, generated 2016 revenue of approximately $1.9 billion and will become part of Thermo Fisher's Laboratory Products and Services segment following the close of the deal.
For Patheon, its pending acquisition by Thermo Fisher continues a multiyear process in which the company has been pursuing a strategy of becoming an end-to-end contract services provider of APIs (both small molecules and biologics) and its historical core competency in formulation development and drug-product manufacturing. The key deal for Patheon dates back to 2014 with the formation of DPx Holdings B.V., privately owned by the private-equity firm JLL Partners (51%) and Royal DSM (49%), which was the result of a $2.65-billion deal between Patheon and DSM completed in March 2014. Since 2012, in addition to DSM Pharmaceutical Products, Patheon has been active on the acquisition front with key acquisitions to build both its API service capabilities and formulation-development and drug-product manufacturing capabilities: Banner Pharmacaps (softgels), Gallus BioPharmaceuticals (biologics manufacturing), Agere Pharmaceuticals (solubilization technology), IRIX Pharmaceuticals (small-molecule APIs), and a former Roche small-molecule API manufacturing site in Florence, South Carolina, which is Patheon's flagship US API operation for commercial-scale and mid-scale API production.
In late June 2017, Patheon announced further investments of approximately $45 million at various sites across its global network. At its API development and manufacturing site in Florence, South Carolina, Patheon will be adding commercial spray-drying capabilities to complement the existing development capabilities at the company's low-solubility center of excellence in Bend, Oregon. The 15,000-square-foot dedicated suite will contain two spray dryers for development- and commercial-scale spray-dried dispersion services. The suite is expected to be on line in 2019. At its Bend, Oregon site, the company plans to expand existing development spray-dried dispersion capabilities with a new cGMP analytical lab, manufacturing suite, and additional development-scale spray drying.
In addition, Patheon has invested in a new commercial sterile-product manufacturing facility at its site in Monza, Italy. The facility will house three, 40-square-meter lyophilizers with associated eight-headed integrated filling equipment for both lyo and liquid formulations for small and large molecules in a range of vial specifications. Patheon also plans to expand its sterile-product Pharmaceutical Development Services (PDS) at the Monza facility to provide development services for both small- and large-molecule injectable products (liquid and lyo formulations), which will be operational in mid-2019.
Patheon is also expanding its packaging and serialization capabilities at its site in Greenville, North Carolina. The company has built a new filling and packaging suite and upgraded another of its packaging lines with new technology to improve efficiency and reduce change-over time. The newly constructed 4,800-square-foot suite will come on line this fall.
Lonza's $5.5-billion acquisition of Capsugel. In another move to build end-to-end capabilities in both APIs and drug products, Lonza, a contract manufacturer of APIs (small molecules and biologics) made a large play with acquisition of Capsugel, a provider of dosage forms, from the private equity firm, KKR, for $5.5 billion in cash, including refinancing of existing Capsugel debt of approximately $2 billion. With the acquisition of Capsugel, Lonza positions itself in the drug-product services sector by gaining oral dosage delivery technologies, including a position in hard-capsule technologies.
The acquisition follows Lonza's opening in November 2016 of a new 1,300-square-meter facility in Basel, Switzerland with drug-product services laboratories with an initial focus on formulation development, drug product analytical development, and quality control for parenteral dosage forms.
Capsugel has made recent investments. Earlier in 2017, Capsugel expanded its late-stage inhalation capabilities to advance dry-powder inhalation concepts through late-stage clinical trial and commercial production. In 2016, it made several key acquisitions: Xcelience, a Florida-headquartered contract development and manufacturing organization specializing in clinical trial material supply and small-scale commercial manufacturing, and Powdersize, a Quakertown, Pennsylvania-based specialist in micronization. In 2015, it completed construction of a new pharmaceutical spray-dried dispersion commercial manufacturing facility at its site in Bend, Oregon as part of a two-year, $25-million investment. In 2015, it announced plans to invest more than $25 million to increase production capacity and deliver further quality enhancements for its vegetarian capsules.
Fresenius Kabi's $4.75-billion buy of Akorn. Another large move in 2017 impacting the contract services market is Fresenius Kabi's $4.75-billion pending acquisition of Akorn. Although the deal was driven by the companies' positions in specialty pharmaceuticals, both companies also have contract manufacturing activities. In April 2017, Fresenius Kabi, a specialty and generic pharmaceuticals company and a subsidiary of Fresenius SE & Co. KGaA, a Bad Homburg, Germany-headquartered healthcare group, agreed to acquire Akorn, a Lake Forest, Illinois-headquartered specialty generic pharmaceutical company. Under the deal, Fresenius Kabi will gain prescription and over-the-counter products, including injectables, topical creams, ointments and gels, and sterile ophthalmics as well as oral liquids, otic solutions, nasal sprays, and respiratory drugs. Akorn's current product pipeline of pending abbreviated new drug applications has a QuintilesIMS market value of $9.3 billion, according to Fresenius Kabi. In addition to gaining a product portfolio, Fresenius Kabi, which provides contract sterile manufacturing services through its Fresenius Kabi Product Partnering division, will boost its contract sterile manufacturing capabilities with the acquisition of Akorn, which also offers that service. Akorn has five manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York; Hettlingen, Switzerland; and Paonta Sahib, India.
Akorn's board recommended approval of the transaction and merger agreement to Akorn's shareholders. The transaction is subject to closing conditions, including regulatory review under the Hart-Scott-Rodino Antitrust Improvements Act in the US and approval by Akorn shareholders. The transaction is expected to close by early 2018.
Going private: Parexel and AMRI. There have been two notable deals in which two now publicly traded contract services firms are being acquired by investment firms and are going private. In June 2017, Parexel, a contract research organization, agreed to be acquired by Pamplona Capital Management, an investment firm, for $88.10 per share or approximately $5.0 billion, including Parexel net debt. The deal would take the now publicly traded Parexel private. The transaction is expected to close early in the fourth quarter of 2017, subject to the approval of a majority of Parexel shareholders and the satisfaction of other customary closing conditions. Upon the completion of the transaction, Parexel will become a privately held company, and shares of Parexel's common stock will no longer be listed on any public market.
In another deal, in June 2017, Albany Molecular Research Inc. (AMRI), a contract research, development, and manufacturing organization, agreed to be acquired by affiliates of The Carlyle Group, an investment firm, and GTCR LLC, a private-equity firm, for $21.75 per share in cash. The agreement was unanimously approved by AMRI's Board of Directors, which has recommended that the shareholders vote in favor of the transaction. Closing of the transaction is subject to customary closing conditions, including, among others, the affirmative vote in favor of the transaction by holders of a majority of AMRI's outstanding common stock and the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and similar laws outside the US. It is anticipated that the special meeting of AMRI's stockholders to vote on the transaction will be held in the third quarter of 2017, and, if the transaction is approved, the merger would be expected to close shortly thereafter.
Other acquisitions. There also have been several smaller acquisitions thus far in 2017. In June 2017, Eurofins Scientific, a provider of biopharmaceutical testing services, acquired Alphora Research, a contract research, development and manufacturing organization of small-molecule APIs based in Mississauga, Ontario, Canada. Alphora has capabilities in multi-step syntheses as well as development of cytotoxic and highly potent APIs. It operates two facilities for API development, testing, and manufacturing.
Also in June 2017, Olon S.p.A., an Italy-headquartered CDMO of APIs acquired the Chemical Division of Concord, Ohio-based Ricerca Biosciences, a contract research organization and CDMO. In 2016, Olon acquired Infa, an Italy-based contract manufacturer of APIs and intermediates. The acquisition of Ricerca provides Olon with US-based manufacturing. With the acquisition of Infa, Olon gained additional manufacturing sites bringing Olon's manufacturing sites to eight European production sites (Rodano, Settimo Torinese, Garbagnate Milanese, Mulazzano, Dorno, Segrate, and Lodi in Italy and one site in Murcia, Spain).
In addition, also in June 2017, Lonza completed the acquisition of PharmaCell B.V., a Netherlands-based cell and gene contract manufacturer with core expertise in autologous cell and gene therapy manufacturing. PharmaCell has more than 6,000 square meters of GMP cleanrooms, quality control, and other support space.
Also this year, Porton Fine Chemicals, a Chongqing, China-headquartered CDMO, acquired J-STAR Research, a contract chemistry organization based in South Plainfield, New Jersey, for $26 million. With the acquisition, Porton, which supplies custom drug intermediates and APIs, expands the reach of its CDMO business. J-STAR offers services to support early-phase clinical development of small-molecule APIs, with its core business covering custom synthesis, process research, crystallization research and development, and analytical services.
Also in 2017, Catalent, a CDMO, completed its acquisition of Accucaps Industries Limited, an Ontario, Canada-based developer and manufacturer of over-the-counter high potency, and conventional pharmaceutical softgels. The company announced the acquisition in November 2016. Also Quotient Clinical, a Nottingham, UK-based early-phase drug development services provider, acquired QS Pharma, a Charles River Laboratories CDMO unit based near Philadelphia. The acquisition expands Quotient's footprint in the US following its recent acquisition of SeaView Research, a Miami, Florida-based clinical research organization.
A roundup of activity: expansions
In addition to mergers and acquisitions, several CDMOs and CMOs are proceeding with expansions. Below is a roundup of noteworthy moves thus far in 2017.
API manufacturing: small molecules
Flamma. Flamma SpA, a Italy-headquartered contract manufacturer of small-molecule APIs opened its new cGMP workshop and Research and Development (R&D) Center in Dalian, China in June 2017. The investment of $20 million brings the total capacity of Flamma's Chinese operations in Dalian to 200 cubic meters and brings its R&D group to the same campus for increased efficiency and productivity. The company has other expansions underway. By 2018, Flamma intends to spend $5 million to expand its R&D capabilities with the addition of a new R&D building at its headquarters in Chignolo d'Isola, Italy. By 2020, Flamma plans to increase its production capacity by 40% with the addition of another cGMP workshop at its Chignolo d'Isola headquarters.
Novasep. Earlier this year Novasep, a Lyon, France-headquartered CMO, opened a new EUR 11-million ($11.6-million) bioconjugation facility at its site in Le Mans, France, for clinical and commercial manufacturing of antibody-drug conjugates (ADCs). The new facility completes Novasep's ADC manufacturing platform, which includes ADC payloads, drug linkers, and monoclonal antibody commercial-scale production capabilities.
STA Pharmaceutical. STA Pharmaceutical, a subsidiary of WuXi AppTec with a technology platform for small-molecule process development and manufacturing, is expanding its new integrated R&D and commercial site in Changzhou, China in stages. On completion, the Changzhou site will include 500 scientists and more than 1000 cubic meters of reactor volume.
The company recently added a new pilot plant and 200 new process R&D scientists. The new pilot plant started operation in November 2016 with 40 reactors ranging from 250 liters to 5,000 liters. In addition, a second commercial plant will be installed in 2017, nearly doubling reactor volume in Changzhou to 490 cubic meters. As of January 2017, Changzhou had 60 reactors with a total reactor volume of 290 cubic meters. The first commercial plant opened a year ago with a milling system recently installed. The Changzhou site, which was officially opened in March 2016, has grown to over 200 scientific personnel including 160 process chemists, 40 analytical chemists, and a specialist group of crystallization technology engineers trained for over a year at the company's Shanghai R&D facility. The 10,000-square-meter R&D center currently has 24 process chemist laboratories and a process safety lab. Another 24 process chemistry labs as well as a catalysis center will be added in Changzhou by the end of 2017. STA plans to have approximately 300 scientists in its R&D teams, consisting of 230+ process chemists and 70 analytical chemists, by the end of 2017 with a focus on antibody drug conjugates and high potent research projects. The Changzhou site has approximately 60 active pharmaceutical ingredients and/or intermediates under development and one new chemical entity in commercial production.
Granules India. Granules India Limited, a Hyderabad, India-based pharmaceutical manufacturing company, received approval for $47.5 million in funding from the International Finance Corporation (IFC), a member of the World Bank Group, for expansion projects, including construction of a new greenfield API facility in Vishakhapatnam, India.
API manufacturing: biologics
Earlier this year, Lonza and Sanofi entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for manufacturing monoclonal antibodies at Lonza's site in Visp, Switzerland. Under the partnership, the companies formed a joint venture which will have an initial investment of CHF 290 million ($290 million), to be split equally between each company.The initial phase of construction will begin in 2017, pending necessary regulatory approvals, and the facility is expected to be fully operational by 2020.
Novasep. Novasep announced an investment of EUR 27 million ($29 million) to build a commercial-scale manufacturing plant for viral vector-based therapeutics at the company's site in Seneffe, Belgium. The new plant is scheduled to be operational in early 2019.
KBI Biopharma. KBI Biopharma (KBI), a biopharmaceutical CDMO, is investing $30 million to expand its biopharmaceutical manufacturing capacity and capabilities at its facilities in Durham, North Carolina and Boulder, Colorado. Additionally, in February 2017, it added to its cell-therapy development and manufacturing operations in The Woodlands, Texas, and recently announced that its parent company, JSR Life Sciences, would acquire Geneva-based Selexis SA, a provider of cell-line technologies. In June 2017, KBI agreed to acquire the assets of San Diego-based Alliance Protein Laboratories, an analytical services company specializing in biophysical characterization of biopharmaceuticals.
Brammer Bio. Brammer Bio, a cell and gene-therapy CDMO, is on track to complete commercial-ready gene therapy manufacturing capacity at its site in Cambridge, Massachusetts, in the second half of 2017. This follows the January 2017 acquisition of Biogen's biologics manufacturing facility in Cambridge and distribution center in Somerville, Massachusetts. Originally built for the manufacture of Biogen's clinical and commercial biologics, the 66,000-square-foot Cambridge facility was licensed by regulatory authorities to manufacture four commercial products. Brammer is renovating the facility for late-stage clinical development and the commercial launch of gene-therapy products. Brammer also acquired Biogen's nearby 49,000-square-foot distribution and warehousing facility. The addition of the Massachusetts facilities gives Brammer 230,000 square feet of development, distribution, and cGMP manufacturing facilities. Brammer had previously announced plans to build out its 50,000-square-foot facility in Lexington, Massachusetts, which is currently being designed for late-stage and commercial cell-therapy supply.
Cobra Biologics. Cobra Biologics, a Keele, UK-headquartered CDMO for biologics and pharmaceuticals, plans to invest up to £15 million ($19 million) over the next two years to expand biopharmaceutical manufacturing operations at its sites in the UK and Sweden. The investment involves a phased expansion plan that supports the company's research and development activities in developing viral vector and DNA plasmid production platforms.
Formulation development and drug-product manufacturing
Lubrizol/Particle Sciences. In June 2017, Lubrizol Corporation announced a $60-million investment in its LifeSciences business, focusing on new product solutions, capacity expansions, and additional cGMP manufacturing to strengthen its excipients, polymers, drug formulation and manufacturing, and medical device contract manufacturing capabilities. Additionally, commercial drug-product manufacturing will be added at the company's Particle Sciences facility in Bethlehem, Pennsylvania adjacent to the company's existing development and clinical trial manufacturing site. The space is expected to be operational in the fourth quarter of 2017 and will accommodate both sterile and non-sterile products, highly potent compounds, and organic-solvent processing. Lubrizol LifeSciences is also investing to expand its global facilities for excipients, polymers, and contract manufacturing. This capital investment will impact multiple sites to increase in-house engineering capacity, which includes design, manufacturing, and sterilization technology for producing interventional catheters and long-term implantable devices.
Alcami. Alcami, a CDMO of APIs and drug products, is investing approximately $5 million to expand its filling and freeze-drying operations at its facility in Charleston County, South Carolina. The site has recently produced clinical supply from its recently qualified second line and doubled both its filling capacity and freeze-drying capacity with increased scheduling, including a third operating shift.
Catalent. In April 2017, Catalent Pharma Solutions announced that it increased its spray-drying capacity at its San Diego, California facility. Catalent gained the facility with its 2016 acquisition of Pharmatek Laboratories, a CDMO in September 2016. The acquisition provided Catalent with early-phase drug-development capabilities, spray-drying capabilities, and expanded Catalent's capability for handling highly potent compounds.
Catalent also completed an expansion at its Kansas City, Missouri facility to increase controlled-temperature storage capabilities for its clinical-supply business. The expansion added 70,000 cubic feet of storage at the site, representing a five-fold increase in controlled-temperature capacity, comprising both pallet and high-density storage options. As part of the expansion, two secondary cold packaging areas were added with the option to add more as needed.
Pfizer CentreOne. Earlier this year, Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, expanded its service portfolio to include contract manufacturing of highly potent solid oral dose medicines. The service will be provided at the Pfizer Newbridge, Ireland facility, now part of Pfizer CentreOne's contract manufacturing network. The addition of solid oral dose manufacturing of highly potent medicines follows an earlier expansion in February 2017 of Pfizer CentreOne's fill-finish services at its Kalamazoo, Michigan site, which now provides vial-filling of sterile suspensions along with vial-filling of small molecules and biologics.
Vetter. Earlier this year Vetter, a Ravensburg, Germany-headquartered CDMO for aseptic filling and final packaging of injectables, began operations in its expanded visual inspection and logistics center in Ravensburg. The company invested approximately EUR 100 million ($107 million) to expand this center to combine capacity for final product inspection and logistics in one site. With the expansion, Vetter now has more than double the capacity for quality-control, cold-storage, and room-temperature storage.
Almac. Almac Group, a Craigavon, Ireland-based CDMO, is expanding in Dundalk, County Louth, Ireland, where it secured premises to build a new facility. Almac will make an undisclosed multi-million British pound investment in the new facility, which will be used by Almac Pharma Services and Almac Clinical Services. The new premises increase Almac's European footprint by 32,000 square feet. The investment follows Almac's previous announcement of approximately £27 million ($34 million) to expand its operations at its global headquarters in Northern Ireland and in North America and to increase its global headcount to 5,000 by 2017.
Griflos Grifols, a Barcelona, Spain-headquartered healthcare company specializing in plasma-derived proteins and contract manufacturer of sterile solutions, recently made investments in sterile-manufacturing technology with the installation of a fourth form/fill/seal (FFS) line in its manufacturing site in Murcia, Spain. The addition of the new FFS line will increase the company's flexible bag manufacturing capacity by 30%. The new line will be operational in 2017 once validations have been completed and approved by Spanish health authorities. Grifols is also waiting for US Food and Drug Administration approval for the new FFS line as part of the company's plan to expand sales of parenteral solutions in new markets. The Murcia facility has also been fitted with a new high-capacity autoclave and a new conditioning line to handle the increased production. Another production line is scheduled to be completed in the company's Parets del Vallés facility in Barcelona, in the first half of 2018.
Recipharm. In April 2017, Recipharm, a Jordbro, Sweden-headquartered CDMO, opened a newly built GMP suite for clinical-trial-material manufacture at its facility in Research Triangle Park, North Carolina. The suite, which represented a $750,000-investment, is for clinical-trial material up to Phase II for non-sterile dosage forms, including metered-dose inhalers and semi-solid topical products. Also, earlier this year, Recipharm completed its previously announced acquisition of Kemwell's pharmaceutical business, Recipharm Pharmaservices Private Ltd, located in Bangalore, India, for Indian rupee 7.98 billion ($120 million).
Piramal Pharma Solutions. Piramal Pharma Solutions, a CDMO, has completed Phase I of a previously announced, two-phase expansion of its sterile manufacturing capabilities at its facilities in Lexington, Kentucky. The $25-million investment, announced in August 2016, is being rolled out in phases.
CoreRx. CoreRx, a Clearwater, Florida-based CDMO, expanded manufacturing and warehousing capacity at its facilities in Clearwater. The expansion is a joint expansion by CoreRx and Aimmune Therapeutics, a clinical-stage biopharmaceutical company, and adds additional staffing at CoreRx, including positions within pharmaceutical development, manufacturing, engineering, quality assurance, and packaging. This new expansion consists of approximately 20,000 square feet of manufacturing and warehouse space.
Recro Gainsville Recro Gainsville, a CDMO and a wholly owned subsidiary of the specialty pharmaceutical company, Recro Pharma, expanded its capabilities by adding a new tablet manufacturing suite. Recro specializes in extended-release and controlled substances.
ProSolus Pharmaceuticals. ProSolus Pharmaceuticals, a Miami, Florida-headquartered CDMO for transdermal and trans-mucosal drug delivery, expanded its manufacturing capabilities for trandsdermal drug delivery. ProSolus is a wholly owned subsidiary of Mission Pharmacal, a San Antonio, Texas-based pharmaceutical company. The expansion included the installation of a second transdermal production facility at Mission's manufacturing site in Boerne, Texas. The Boerne location houses a larger production line than Prosolus' two manufacturing facilities in Miami, and the expansion at Boerne more than doubles the company's total transdermal product output. Combined, the capacity of the two locations is now more than 100 million patches annually.
Ciron Drugs & Pharmaceuticals. Ciron Drugs & Pharmaceuticals, a Mumbai, India-based CDMO, launched a 80,000-square-foot-sterile manufacturing facility. The new facility can produce 200,000 units of ampuls per shift, 100,000 units of vials per shift, 80,000 units of lyophilized vials per cycle, and 40,000 units of eye drops per shift.
AB BioTechnologies. Earlier this year, AB BioTechnologies, a drug-development services company located in Bloomington, Indiana, announced plans to add contract clinical manufacturing operations by investing $10.5 million to construct and equip a 23,000-square-foot facility. The facility will include a manufacturing area for formulating, filling, lyophilizing, and packaging drugs for early-phase clinical trial studies. The company plans to open the new facility in November 2017.
The Year Ahead: What's on the Minds of CEOs?
Economic uncertainty, supply chain, talent management, and risk mitigation were key issues cited by CEOs in PwC's Global CEO survey, released at the World Economic Forum in Davos, Switzerland. What are key takeaways from a study of 4,400 CEOs?
Big Pharma's Growth Initiatives in 2023: Part 2
More coverage of the J.P. Morgan Annual Healthcare Conference in San Francisco earlier this month, where bio/pharma industry executives highlighted their companies' strategies and key growth initiatives. What are more highlights?
The CDMO/CMO Report: The Year Ahead in Bio/Pharma Outsourcing
What can the markets for bio/pharmaceutical outsourcing expect in 2023? DCAT Value Chain Insights examines key trends and highlights in major manufacturing segments: API and drug-product manufacturing.
Big Pharma Strategies and Growth Initiatives: What's In Store for 2023
At the J.P. Morgan Annual Healthcare Conference in San Francisco this week, bio/pharma industry executives highlighted their companies' strategies and key growth initiatives.


text:
Het Vorstendom Lucca en Piombino (Italiaans: Principato di Lucca e Piombino) was een napoleontische staat in Toscane (Italië) van 1805 tot 1815.

De Noord-Italiaanse stad Lucca, met het omringende land, was oorspronkelijk een republiek. In 1799 kwam Lucca onder Frans bewind, en in 1805 werd het een klein onafhankelijk vorstendom door toedoen van de Franse keizer Napoleon, die er zijn zus Elisa Bonaparte als prinses van Lucca en Piombino op de troon plaatste (Piombino in maart 1805 en Lucca in juni 1805), met haar man Félix Baciocchi als prins-gemaal. In 1809 werd Elisa groothertogin van Toscane en voegde Napoleon Lucca en Piombino toe aan Toscane.

Het Congres van Wenen verving in 1815 het vorstendom door het hertogdom Lucca en plaatste de staat onder het bewind van de Bourbons, ter compensatie van het verlies van het hertogdom Parma, dat aan Napoleons voormalige echtgenote Marie Louise van Oostenrijk werd toegewezen. Piombino werd door het Congres van Wenen aan het groothertogdom Toscane toegekend.

Zie ook
Lijst van heersers van Piombino
Vorstendom Piombino

Geschiedenis van Lucca
Lucca
Lucca
Lucca


As I write this, I'm sitting in my hotel room, plotting my sunset adventure for my last night in Mount Rainier National Park. I've been here a few times already, the first back in 2009 (before I was into landscape photography, go figure!), and then again three years ago (in 2012). I was hoping to get away from the heat wave we've been having in Portland, as well as to get out and use my camera (which has been collecting dust far too long this summer).
This time of year, there is usually an abundance of wildflowers blooming all over the park. In fact, the last time I visited was in the month of September, and the fields were filled with colorful flowers. However, the sky was so foggy that I never even saw the mountain!
On this trip, aside from an epic sunset on the first night, I am having the opposite problem: very few wildflowers, and clear skies. The wildflower bloom was early this year, likely due to the heat and lack of rain we have had in the Pacific Northwest, and so there are only a few colorful flowers scattered throughout the park. But I'm still having a really nice, relaxing time, and also getting some great photos.
Be sure to follow me on Instagram to view more photos from this and other adventures.


text:
Вулиця Підгородня — вулиця в мікрорайоні «Старий парк» міста Тернополя.

Відомості
Розпочинається від вулиці Михайла Коцюбинського, пролягає на схід, перетинаючись з вулицею Степана Чарнецького, де і закінчується. На вулиці розташовані переважно приватні будинки.

Освіта
 Вечірня школа (Підгородня, 1)

Транспорт
Рух вулицею — двосторонній, дорожнє покриття — асфальт. Громадський транспорт по вулиці не курсує, найближчі зупинки знаходяться на проспекті Степана Бандери та вулиці Веселій.

Див. також
 Вулиці Тернополя

Посилання
 Вулиця на карті

Вулиці Тернополя


text:
Aug. 31, 2021 COVID-19 Update: 553 New Cases in Hawai'i
August 31, 2021, 9:56 AM HST
* Updated September 1, 6:46 PM
(L to R) Christin "Kiki" Quarry RN; Dr. Vincent Truong; and Kolonahe "Kolo" Plunkett, hospital aide. Plunkett lost his brother to COVID-19 shortly before Christmas last year. PC: Maui Health
There were 553 additional COVID-19 cases in Hawai'i on Tuesday. The latest data represents an average of 911 cases per day for the state over the past seven days, and a total of 11,045 "active" cases over two weeks. This spike in cases comes amid a rise in cases involving the Delta variant.
Of today's 553 cases, there were 549 cases identified as confirmed, and four probable cases were added to the count. The confirmed cases included: 431 on O'ahu (-1 probable); 61 on Hawai'i Island (+4 probable); 37 on Maui; 12 on Kaua'i (+1 probable); and eight in Hawai'i residents diagnosed while out of state.
Today's COVID case count includes all cases from the regular 24-hour reporting cycle that ended at 11:59 p.m. Sunday.
In Maui County, there is an average of 82 new cases with a 6.6% test positivity rate over 14 days. This marks a 16% increase from Aug. 16 to Aug. 29, 2021. For every 100,000 residents in Maui County, there have been an average of 49 newly reported cases per day over the last seven days.
Aug. 31, 2021. PC: Hawaiʻi Department of Health.
Statewide, there were 432 people hospitalized with COVID-19 on Tuesday (378 or 88% unvaccinated / 54 vaccinated), according to Lt. Gov. Josh Green. This is up +162% from the 165 hospitalizations reported on Aug. 5, 2021. The state's positivity rate is now at 7.9%.
There are a total of 26 individuals hospitalized in Maui County with COVID-19, (20 are unvaccinated and six are vaccinated) according to counts last updated on Aug. 31, 2021, from Maui Health. Of that number, six COVID patients are in the ICU and one is on a ventilator.
Aug. 31, 2021. PC: Maui Health
Maui police have confirmed the there are 60-shelves within the Forensic Facility Morgue. As of Aug. 27, 2021, 18 spaces within the Morgue were occupied. Maui County has a 40-foot refrigerated container with a 40-shelf capacity for morgue overflow body storage. The County container was purchased in early 2020 to increase the morgue capacity in general, but also in response to COVID-19, according to Maui Police Department spokesperson Alana Pico.
Hospital executives acknowledged that the recent surge in COVID cases is taking a toll on the hospital and that more staff is needed. Twenty FEMA nurses were due to arrive last week, with more arriving this week.
Through Aug. 30, 2021, an estimated 1,863,219 doses of vaccine have been administered statewide. The state's total population is 1,415,857. The DOH reports that 71.4% of the state population has had one dose of vaccination, and 63.1% have completed full vaccination. On Maui, the DOH reports that 66% of the total population in Maui County has initiated a vaccine, while 56% have completed a full course of vaccination.
As case counts have escalated, Hawaiʻi has experienced an increase in the number of vaccine doses administered. During the past seven days the number of vaccine doses reported to have been administered has grown from 1,820,538 to 1,848,431. That is an increase of 27,893 doses over the past seven days. The weekly vaccine count has increased for four consecutive weeks as shown below:
Aug. 21-27: 27,893 doses
Aug. 7-13: 22,842 doses
July 31 – Aug. 6: 20,006 doses
July 24 – 30: 14,670 doses
Vaccination Requirement Announcements:
State & County Workers: On Thursday, Aug. 5, Governor David Ige announced that all state and county employees are required to provide their vaccination status to their department, office or agency. If they cannot provide proof of vaccination by Aug. 16, they will be subject to regular COVID-19 testing.
State House Members: Also on Aug. 5, the state House announced it would be implementing a vaccine requirement for members and staff by Sept. 30, 2021.
Student Athletes, Staff, Volunteers: On Wednesday, Aug. 4, the state Department of Education announced all student-athletes, athletic staff and volunteers will need to be fully vaccinated by Sept. 24, 2021, to participate in school-sanctioned athletic activities for the 2021-22 school year.
Three Hawaiʻi banks: Bank of Hawaii, First Hawaiian Bank and Territorial Savings Bank–announced that effective Sept. 30, they will require employees to show proof of full vaccination or undergo weekly COVID-19 testing. Hawaiʻi State Federal Credit Union is the latest to announce it will require all of its 369 employees on Oʻahu and Maui to be fully vaccinated for COVID-19 by Oct. 1, 2021.
Maui Healthcare Providers Join in Announcing COVID-19 Vaccine Mandate: Kīhei-Wailea Medical Center and Maui Medical Group have joined Maui Health, which includes Maui Memorial Medical Center, Kula Hospital and Lānaʻi Community Hospital, in mandating the COVID-19 vaccine for all eligible employees and providers. All health care entities will follow their company vaccine mandate policy, which will include exemptions for a medical condition or a sincerely held religious belief that prohibits someone from receiving the vaccine.
DOE to Implement Weekly COVID-19 Testing Requirement for Employees, Volunteers: If an employee can certify and provide proof of full vaccination, the employee will not be subject to the weekly testing requirement. This requirement applies to all HIDOE employees, including salaried and casuals/substitutes, as well as volunteers.
Of the 6,297 confirmed cases documented in Maui County over the course of the pandemic, Kahului has the most current infections on island over the past two weeks with 254 cases, followed by Wailuku with 241, and Lahaina with 213 current infections. The three locations have entered the 200+ mark for active infections.
Kīhei has 154 cases, followed by Makawao with 121. The two locations are included in the dark blue category (51-200 cases) on DOH mapping.
Areas in the medium blue category (11-50 cases over two weeks) include: Haʻikū with 45 cases, Kula with 48 cases, Spreckelsville with 33 cases, and Hāna with 17 cases.
There are 6,297 confirmed cases documented in Maui County over the course of the pandemic, plus an additional 1,368 probable cases, bringing the total cases attributed to the county to 7,665.
The state Department of Health has now lumped the probable and actual cases classified by zip code. The new totals are: Kahului (1710), followed by Wailuku (1550), Lahaina (1482), Kīhei (1105), Makawao (517), Haʻikū (278), Kula (205), Molokaʻi (159), Lānaʻi (131), Spreckelsville (122), and Hāna (43).
Cluster report: Updated Weekly (Aug. 19, 2021)
*Next cluster report is due out on Sept. 4, 2021
The cluster report, which covers the period through Aug. 19, 2021, identified 21 active clusters in Maui County. There's five clusters each in occupational settings and travel/lodging/tourism; two clusters each in educational settings, social gatherings and "other" locations; and once cluster each in a correctional facility, food supplier restaurant, construction/industrial site and a gym.
To date, there have been 589 COVID-19 related deaths in Hawaiʻi including: 455 on Oʻahu, 69 in Maui County, 59 on Hawaiʻi Island, three on Kauaʻi and three deaths in residents diagnosed while out-of-state including one of an elderly Kaua'i resident who died out of state, in Arizona, and another involving a male between the ages of 60-69 years old with underlying medical conditions who had been incarcerated out of state and died at a hospital.
Honolulu Mayor Blangiardi announced a Safe Access Oʻahu Program that starts Sept. 13, 2021
(Aug. 29, 2021) Hawai'i's COVID-19 deaths increased to 589, with two new deaths reported today, both on O'ahu, including two women–one in her 60s and another in her 70s. Both were hospitalized with underlying conditions.
(Aug. 28, 2021) Hawai'i's COVID-19 deaths increased to 587, with five new deaths reported today. The state Department of Health reports the deaths included four individuals on O'ahu and one on Moloka'i. This is the first COVID related death for the island of Moloka'i since the pandemic began.
(Aug. 27, 2021) Hawai'i's COVID-19 deaths increased to 582, with nine new deaths reported today–all on Oahu. The state Department of Health reports the deaths involved: a woman in her 50s, two men in their 50s, a man and woman in their 60s, and a woman and three men in their 70s. All had underlying conditions, and all but one were hospitalized at the time of their death. One on the men, between 70-79 years old died at home.
(Aug. 25, 2021) Hawai'i's COVID-19 deaths increased to 573, with eight new deaths reported today, including seven on O'ahu and one on Maui. The O'ahu deaths involved a woman in her 30s, a man in his 40s, a woman her 50s, a man in his 60s, a woman in her 70s, and two men in their 80s. All were hospitalized with underlying conditions. The Maui death involved a man in his 70s who had underlying conditions and died at home.
(Aug. 24, 2021) Hawai'i's COVID-19 deaths increased to 565, with one new death reported today on O'ahu, involving a man in his 80s who was hospitalized with underlying conditions.
(Aug. 22, 2021) Hawai'i's COVID-19 deaths increased to 564, with one new death reported today on Maui. The state Department of Health reports that today's death involved a Maui woman in her 30s who was hospitalized with underlying conditions.
(Aug. 21, 2021) Hawai'i's COVID-19 deaths increased to 563, with one new death reported today on Maui. The state Department of Health reports the death involved a Maui man in his 50s with underlying conditions, who died at home.
(Aug. 20, 2021) Hawai'i's COVID-19 deaths increased to 562, with four new deaths reported today–two on Maui and two on O'ahu. The state Department of Health reports the deaths involved: two men on Maui–one in his 50s and one in his 70s; and two men on O'ahu–one in his 60s and one 80 years or older. All were hospitalized with underlying conditions.
(Aug. 19, 2021) Hawai'i's COVID-19 deaths increased to 558, with four new deaths reported today–three on O'ahu, and one on Kaua'i.
(Aug. 15,2021) Hawai'i's COVID-19 deaths increased to 552, with four new deaths reported today on O'ahu. The deaths involved: a man in his 40s who was hospitalized with underlying conditions; a woman in her 40s who was hospitalized with underlying conditions; a man in his 50s who was died at home with underlying conditions; and a man in his 60s who was hospitalized with NO underlying conditions.
(Aug. 14, 2021) Hawai'i's COVID-19 deaths increased to 548, with one new death reported today on O'ahu. The death involved a man in his 60s who was hospitalized with underlying conditions.
(Aug. 13, 2021) Hawai'i's COVID-19 deaths increased to 547, with one new death reported today on O'ahu. The death involved an O'ahu man in his 70s who was hospitalized with underlying conditions.
(Aug. 11, 2021) Hawai'i's COVID-19 deaths increased to 545, with two new deaths reported today on O'ahu. The deaths involved: two women–one in her 40s and another in her 80s, both who were hospitalized with underlying conditions.
(Aug. 8, 2021) Hawai'i's COVID-19 deaths increased to 543, with one new death reported today on O'ahu. The death involved an O'ahu man in his 70s who was hospitalized with underlying conditions.
(Aug. 6, 2021) Hawai'i's COVID-19 deaths increased to 540, with two new deaths reported today. The deaths included an O'ahu man in his 70s and a Hawaii Island man in his 70s. Both were hospitalized with underlying conditions.
(Aug. 3, 2021) Hawai'i's COVID-19 deaths increased to 538, with one new death reported today. The death involved a Maui woman in her 70s who was hospitalized with underlying conditions.
(July 30, 2021) Hawai'i's COVID-19 deaths increased to 537, with three new deaths reported today–one on Maui and two on O'ahu.
(July 29, 2021) Hawai'i's COVID-19 deaths increased to 534, with two new deaths reported today–one on O'ahu and one on Hawai'i Island.
(July 28, 2021) Hawai'i's COVID-19 deaths increased to 532, with three new deaths reported today–two on Maui and one on Hawai'i Island. The Maui deaths included a man and a woman, both in their 70s who were hospitalized with underlying conditions.
(July 22, 2021) Hawai'i's COVID-19 deaths increased to 527, with three new death reported today.
(July 21, 2021) Hawai'i's COVID-19 deaths increased to 524, with one new death reported today on O'ahu.
(July 15, 2021) Hawai'i's COVID-19 deaths increased to 522, with one new death reported today on Hawai'i Island
(July 10, 2021) Hawai'i's COVID-19 deaths increased to 521, with two new deaths reported today on O'ahu.
(July 8, 2021) Hawai'i's COVID-19 deaths increased to 519, with one new death reported today on O'ahu.
(June 26, 2021) Hawai'i's COVID-19 deaths increased to 516, with two new deaths reported today on O'ahu.
(June 25, 2021) Hawai'i's COVID-19 deaths increased to 514, with one new deaths reported today on Hawai'i Island.
Hawai'i Coronavirus Total Now 553: 12 New Cases,… April 17, 2020
Aug. 12, 2021 COVID-19 Update: 549 New Cases in… August 12, 2021
Aug. 13, 2021 COVID-19 Update: *1,167 New Cases in… August 13, 2021
Aug. 16, 2021 COVID-19 Update: 539 New Cases in Hawai'i August 16, 2021


Just over three years ago, I got married to a wonderful guy named Brian.
I've traveled more than ever before. Brian and I celebrated our honeymoon in London. I went to the West Coast for the first time to attend search engine conferences, with trips to Seattle, San Jose (twice!), and Las Vegas.
I started writing for some of my favorite blogs in the industries and topics I'm most passionate about.
Right after college, I worked for a few months in tech support at a forex company in the Empire State Building. I remember working there on Thanksgiving Day and having a super awesome view of the Macy's Day Parade.
I then worked for several months prior to my marriage as a private investigator. It wasn't the kind of job that requires spying on cheating husbands, though. As a PI, I researched trademarks and products that may have had conflicting names with existing trademarks and I reported on the findings. It was actually a very interesting line of work.
In college, I worked as a student network technician and a Unix systems administrator. I still find IT interesting, but I'm much happier doing what I do now.
What is it, then, that I do now? You could call me a blogger of many hats or a social media maven or Internet marketing consultant. I really don't know, and that's what makes what I do so exciting. The answer changes everyday!
My first stop every day (and numerous other periods during the day) is my email, which is hosted on Gmail or Google Apps.
I consume my news via Bloglines.
My favorite restaurant is Sara's Pizza in Miami. They have pretty darn good pizza, but my favorite dish is their calzone, which is filled with black olives, ricotta cheese, mozzarella cheese, sauteed onions, and green peppers. Miguel Lopez took a picture of me and the meal when we met in September.
I absolutely love kreplach in chicken soup (or even in vegetable soup — I can handle it anywhere!) Kreplach are like wontons, only with a much doughier outside and tastier meat inside. If you go to Mr. Broadway in Manhattan, ask for the soup. It's awesome.
I'd probably say that my favorite cuisine is Indian, but probably because I never get too much of it. Prior to Austin (where I had to go outside the city in order to get Kosher food for SXSW), the last time I ate Indian food was in 2003. On that note, thank you to Jane for taking me out there to ensure I had something (great) to eat!
I'm a sucker for sweets, particularly if milk chocolate is the primary ingredient. Brownies, Kit-Kat, and Reese's Cups are three of my favorite chocolate foods.
You can answer any of these questions: 4 Jobs I've had, 4 Favorite Foods, 4 TV Shows I DVR, 4 Movies I could watch Over & Over, 4 Places I've been, 4 Places I've lived, 4 Places I want to go, 4 Music Artists I'm listening to now, 4 All Time Favorite Musicians, 4 Shows I have been to, 4 Cars I have owned, 4 Things I have done in the past 4 years, 4 websites I visit daily, 4 places I'd rather be right now, 4 People I think will respond, 4 Things I look forward to this year, or 4 Underrated conversational topics. Enjoy!
Thanks for the link love and the response. I'm looking forward to meeting you next weekend for the Social. And I'll be sure to keep you on my good side (OMG a PI!).
I'm not tagging anyone because the links would take too much time. I tag Tamar to answer four more questions (different ones).
The redesign looks great! Keen branding choice with the logo. The 'rss guy' on the can is AWESOME.


baby boy holiday clothes cute newborn boys girls first uk . baby boy holiday clothes romper first kids xmas .
baby boy holiday clothes infant . baby boy holiday clothes newborn kids girls outfits tops batman pants set in clothing sets from .


text:
Sacred Truth Ministries
Sacred Truth Publishing / Ministries & Services
ORDER INFORMATION / Contact Info. / Postage & Handling
You're in the Army now... I now present to you "Brigadier-General Jen der Kunphiuzhon"
By Robertiu on Mon, 10/02/2017 - 09:33
http://www1.cbn.com/cbnnews/us/2017/july/army-transgender-training-naked...
HOW SANE IS IT...? and HOW IS IT NOT A MATTER OF NATIONAL SECURITY (though it certainly does not need to be a secret) to allow a man into the army who thinks he is a woman?
WHAT IF, during a U.S. war against Korea, he-she suddenly feels the urge to "identify" with and "think" that he-she is an American trapped in a Korean's body? and in the middle of a battle "realize" that he-she is fighting on the wrong side of the war and then starts killing American women in the barracks he-she is stationed in? What if private he-she tells the army that he-she identifies with and thinks that he-she is a 5-star general trapped in a private's body...? It reminds me of the email someone sent around about the new war movie called, "Saving Ryan's Privates". War is not a bad prom night! Furthermore, it is not merely the soldiers in the war whose lives are at stake—but the lives of everyone in the nation whom they are supposed to be protecting, rather than kowtowing to mentally deranged gender-confused individuals. Back in the 70s with the long-running, popular T.V. series M*A*S*H, Lebanese actor Jamie Farr (Jameel Joseph Farah) played Maxwell Q. Klinger, who dressed as a woman in gaudy clothes, hoping for a Section-8 dismissal from the Army. Now they do it in real life and hope for a promotion...!
Where will it end...? When you enter someone elses perverse delusion with him-her, there are no rules and you must go with the flow.
[Great, now my white cat Prissy thinks that she is a black dog and wants me to call her "Butch" and instead of calling "here kitty, kitty", she wants me to yell, "Wher dat dirty dawg!" She also wants me to take her for training to become a police dog to protect black drug dealing criminals on welfare (who feel that they are and identify with being non-white law-abiding citizens with jobs who earn paychecks as vitamin salesmen) from police brutality. When I tell her to stand up straight so I can groom her, she takes the knee and looks at me defiantly and starts singing, "We shall overcome" and "swing low sweet chariot". She also says that dogs don't bury their doody so I am going to have to follow her around with a pooper scooper from now on. It was my fault for letting her watch t.v. Now her head is filled with all sorts of nonsense. To make matters worse, her fleas think that they are butterflies and the rats in the ally are claiming that they identify with being puppies and say they are going to report me to PETA for abandonment and poisoning. The new smart meter they put on my house is claiming it is actually stupid so it can't be held responsible for any health hazards or spying.
Maybe when I go to buy a new car I will tell the car dealer that my twenty $1 bills identify with and think that they are $1,000 bills trapped in $1 bills' bodies. Hmmm... maybe I am on to something. My 1980 Ford pickup heard that they are giving out-of court settlements to owners of 2015 Toyotas and my Ford now identifies with and thinks it is a 2015 Toyota trapped in a 1980 Ford's Body and keeps singing, "Oh what a feeling... Toyota!" I feel like and identify with being a Trump trapped in a Balaicius body and want my back-allowance that Donald hasn't paid me weekly for the past 55 years.]
Maybe all poor white people ought to declare that they "identify with" and "believe" that they are blacks trapped in white men's bodies—and they can apply for food stamps, welfare, free health care, be given more-lenient sentences for crime, and can get affirmative action high-paying jobs without having any real skills or knowledge...?
— Robert's Ruminations - Important Thoughts Rarely Discussed in the Mainstream
— Health Bulletin Board
— Uncategorized
— Books Written by Robert Alan Balaicius (with PDF of all titles written & edited by RAB)
— Books Edited by Robert Alan Balaicius
— Rare Books Reprinted by Sacred Truth Publishing — 2018
— Rare Books Reprinted by Sacred Truth Publishing — 2017 and earlier
— Rare Books Reprinted by Sacred Truth Publishing
— Reformation Books reprinted by STP/STM
— Uncategorized (and PDFs of complete catalogs)


Buy Climate Control with SenePlex by SeneGence. Sold by SeneGence Distributor in Brisbane, Donna Power.
Previous: Previous post: Buy Climate Control with SenePlex by SeneGence. Sold by SeneGence Distributor in Brisbane, Donna Power.


A share of $500 million worth of water infrastructure projects is available to state and territory governments, which are being urged to apply for funding and undertake infrastructure upgrades in regional communities.
Deputy Prime Minister and Minister for Infrastructure, Transport and Regional Development, Michael McCormack, said the fund was expanded to co-invest in even more projects to further enhance water security and unlock regional Australia's huge social and economic potential.
"The Liberal and Nationals Government knows water is our greatest resource and if our regions have access to more secure water supplies our towns can prosper and our agricultural industries can thrive," Mr McCormack said.
"That is why this government is investing in water infrastructure, heralding a new era for our regional communities and our regional economies.
"We are not afraid to put our regional communities first and deliver the water infrastructure they expect and deserve.
The Liberal and Nationals Government's investment under this fund now totals more than $1.3 billion.
Information, guidelines and related forms are available at infrastructure.gov.au/infrastructure/water-infrastructure/nwi-development-fund.


text:
Q: clarify behaviour: collections.defaultdict vs dict.setdefault dict provides .setdefault(), which will allow you to assign values, of any type, to missing keys on the fly:
>>> d = dict()
>>> d.setdefault('missing_key', [])
[]
>>> d
{'missing_key': []}

Whereas, if you use defaultdict to accomplish the same task, then the default value is generated on demand whenever you try to access or modify a missing key:
>>> from collections import defaultdict
>>> d = defaultdict(list)
>>> d['missing_key']
[]
>>> d
defaultdict(<class 'list'>, {'missing_key': []})

However, the following piece of code implemented with defaultdict raises a KeyError instead of creating the item with default value, {}:
trie = collections.defaultdict(dict)
for word in words:
    t = trie
    for c in word:
        t = t[c]
    t["*"] = word

Using .setdefault() works ok:
trie = {}
for word in words:
    t = trie
    for c in word:
        t = t.setdefault(c, {})
    t["*"] = word

checking before access, works ok too:
trie = {}
for word in words:
    t = trie
    for c in word:
        if c not in t:
           t[c] = {}
        t = t[c]
    t["*"] = word

What am I missing when using collections.defaultdict()?
NB
I am trying to build a Trie structure out of a list of words. For example:
words = ["oath", "pea", "eat", "rain"]
trie = {'o': {'a': {'t': {'h': {'*': 'oath'}}}}, 'p': {'e': {'a': {'*': 'pea'}}}, 'e': {'a': {'t': {'*': 'eat'}}}, 'r': {'a': {'i': {'n': {'*': 'rain'}}}}}

A: In your first example, when you do t = t[c], t becomes a regular empty dict (because that's what you tell the defaultdict to generate in the definition of trie).
Let's run through the loop with your example word "oath":
1) t = trie, word = "oath"
2) c = "o"
3) t = t[c]
  3.1) evaluation of t[c] # "o" is not in trie, so trie generates an empty dict at key "o" and returns it to you
  3.2) assignment to t -> t is now the empty dict. If you were to run (t is trie["o"]), it would evaluate to True after this line
4) c = "a"
5) t = t[c]
  5.1) Evaluation of t[c] -> "a" is not in the dict t. This is a regular dict, raise KeyError.

Unfortunately, I can't think of a way to use defaultdict here (but Marius could, see this answer), because of the arbitrary nesting of a Trie. You'd need to define the trie as a defaultdict that, in case of missing key, generates a default dict that itself generates a default dict in case of missing key, recursively until maximum depth (which, in principle, is unknown).
IMO, the best way to implement this is with the setdefault as you did in your second example.

A: GPhilo's answer is perfectly fine and, indeed, I also believe that setdefault is the proper way of doing it.
However, if one prefers to use the defaultdict, it can be easily achieved like this:
def ddnestedconst():
    """collections.defaultdict nested-ish constructor."""
    return collections.defaultdict(ddnestedconst)

# ...

trie = collections.defaultdict(ddnestedconst)
# or, being the same:
#trie = ddnestedconst()

for word in words:
    t = trie
    for c in word:
        t = t[c]
    t["*"] = word

May feel a little bit strange at first, but I find it perfectly readable and semantically accurate.
Reached that point, you may also prefer to create a new class altogether, inspired by defaultdict, but including all the semantics and specific behaviour that you expect from it.

redpajama_set_name: RedPajamaStackExchange


text:
Douglas Elliman's officially open for business in "kitschy" Tampa
The brokerage's Florida-based CEO says he's also planning offices in Naples, Sarasota
May.May 12, 2019 01:00 PM
Jay Phillip Parker, Tampa (Credit: Twitter, iStock)
Douglas Elliman has officially opened its first office in "kitschy-esque" Tampa.
Yes, that was Elliman's Florida CEO Jay Phillip Parker's description of the brokerage's latest outpost in the Sunshine State, as stated in an interview with the Tampa Bay Times.
He said the Tampa office's opening comes as the brokerage is seeing heightened interest in west coast cities like Sarasota, St. Petersburg and Tampa from within the state.
"It's generally more of the Midwestern type buyer on the west coast, but we see that shifting. We see more and more people from the east coast looking at the west coast. It's a more conservative buyer, a more reserved buyer," he said.
Parker believes lower home prices are a major part of the lure.
"Prices on the west coast are probably at least 30 percent [than on the east coast]," Parker told the Times. Luxury prices in Miami $3,000 per square foot, and on the west coast of Florida, "I don't think you have anything that comes close to that."
Since opening in February, he claims Elliman's office in St. Petersburg has closed $21 million of home sales. The brokerage entered the Tampa-area market by acquiring St. Petersburg brokerage firm Strickland Property Group, increasing its network in Florida to 22 offices (including 21 on the east coast) and more than 1,100 agents.
Parker said he plans to add as many as a dozen agents at the St. Petersburg office, and will probably open its second office on Florida's west coast in Naples in 2020. He said Elliman has also considered opening an office in Sarasota. [Tampa Bay Times] – Mike Seemuth
douglas ellimanResidential Real Estate
Cavache taps Douglas Elliman to sell remaining units at 30 Thirty North Ocean in Fort Lauderdale Beach
Movers & Shakers: RelatedISG names vice president & more
South Florida's juiciest real estate lawsuits of 2020
Lawsuit alleges Harding Realty cut out of $24M Bal Harbour sale, reveals Chewy founder as alleged buyer
Lourdes Alatriste leaves Engel & Völkers to join Douglas Elliman


text:
Derren Brown: Showman Tickets at the The Lowry - Lyric Theatre, Manchester
Derren Brown brings Showman to Manchester's Lyric Theatre at The Lowry
Derren Brown returns to the stage with his brand-new live show!
The multi award-winning master of mind control and psychological illusion, Derren Brown, is at his very best on stage. His one-man shows have received wide critical acclaim and more Olivier wins and nominations than any other in history!
Now with his first brand new theatre show in six years, Derren Brown returns to astonish and amaze audiences up and down the country. The content of Showman remains a closely-guarded secret, but if you've seen him before, you know you're in for a powerhouse treat!
"All I can reveal is that the show will ultimately be about you, the audience member, because that's what I find most interesting. There are places I'd like to take the audience where we haven't been before. I always aim to have it deliver more than you'd expect. I'm excited to be at the starting point of that process. Getting it on the road will be my favourite part of the year." Derren Brown
Suitable for ages 12+. Children under 12 will not be permitted.
8 June 2021 - 19 June 2021
Next Available Performances of Derren Brown: Showman
8th June 2021 20:00 Tuesday
Derren Brown: Showman
9th June 2021 20:00 Wednesday
10th June 2021 20:00 Thursday
Booking from 08 June 2021
to 19 June 2021
The Lowry - Lyric Theatre Pier 8, The Quays, Salford, Manchester, M50 3AZ


text:
import React from 'react';
import {Link} from 'react-router';

const LoginLink = () => {
  return (
    <span>
      <Link to="/register" activeClassName="active">Sign Up</Link>
      {" | "}
      <Link to="/login" activeClassName="active">Login</Link>
    </span>
  );
};

export default LoginLink;

redpajama_set_name: RedPajamaGithub


JOB DESCRIPTION The specific duties of this position include, but are not limited to, the following: -Assist in recording, classifying and summarizing of the financial transactions of IUCN ORO and ensure proper update and maintenance of ERP – Navision ensuring the accounting system provides the basis for an efficient financial information system for both internal and external users and that it is compliant with internationally accepted accounting principles, legal and statutory requirement and IUCN policy. -Assist in reviewing of all accounting related transactions (payment vouchers, receipts vouchers, debit and credit notes, staff time invoices, correcting journal entries) prior to entry into the accounting system -Assist and ensure that all balance-sheet accounts and trial-balance are reconciled in accordance with IUCN accounting policies and procedure -Assist in preparation of ORO cash flow projection and monitor the continued availability of funds to cover the requirements of ORO operations and its programmes and projects -Review and ensure that disbursements are properly supported with relevant documentation and that they are properly identified into their project codes -Ensure that cash, credit card and bank balances are reconciled with the records maintained in accordance with IUCN Accounting policies -Responsible for the maintenance of Fixed Asset Register, recording, updating and reconciliation on a timely basis -Assist and ensure that monthly financial closing is carried out on a timely basis – staff time invoices raised and entered into ERP, management overhead charges are recorded accurately and the necessary entries are made in accordance with Monthly Financial closing requirements -Arrange and manage internal and external audits of the project and operational finances in accordance with IUCN policies and procedures and donor requirements; -Assist in providing training and guidance to IUCN staffs on financial policies and procedures where necessary; -Maintain proper filing of updated documentation including agreements, budgets, reports, Internal Agreements, staff time sheets , correspondence with donor, implementing partners, contractors and other relevant documents; -Ensure that reports from implementing partners, sub-contractors, consultants and others are received and reconciled in accordance with schedules in agreements, are in compliance with donor and IUCN guidelines. -Receive, review and prepare request funds transfers to implementing partners in accordance with agreements, budgets, expenditure reports and cash flow forecasts; -Prepare and disseminate project management reports to Project Manager/s on a monthly basis or as required; -Assist and undertake budget reviews and the preparation of the annual budget and work plan in consultation with the Project Manager/s; -Assist in preparation of travel arrangements and other project related activities as required by the Project Manager/s; -Visit project sites, including those of hosting agencies and implementing partners to review expenditure records, contracts, time-sheets and other support documents, conduct training in IUCN policies and procedures, donor guidelines, taxation and other compliance related matters; -Carry out any other relevant task required by, and mutually agreed with, the line manager/s and or Regional Head of Finance & Administration.


Why You Must Take Bookkeeping Courses if You Choose to Walk Down That Path?
Over the years, you could definitely find a number of things that were once concepts of the mind but are now becoming a reality. You could find that there are just so many things that we could find today and to incorporate bookkeepers and accounting system training in businesses really is a great way to ensure you are seeing a great improvement from your investment. Get more information about bookkeepers Melbourne.
In a way, you could find and see that online accounting software has been around and is being used by quite a number of businesses today because of it being that this helps in terms of increasing productivity and work. This basically is a great way for you to see and ensure that you will then achieve stability in terms of holding and handling your finance. There really are a plethora of advancements you will find from such and we will be talking more about it just so you will increase such understanding.
As much as possible, you have to be specific and on point about going with one that is user friendly. In the world of business, efficiency is what saves you time, reason why it should be straightforward and that it should not take much of your time just to learn the ins and outs of the system. Remember that it will definitely be in your best interest if you are to choose one that has systems that is easy to understand and comprehend. For more information about the XERO setup , follow the link.
Keep in mind that security also is something you need to specifically concern yourself about. It is just important for businesses to make sure that data is being stored accordingly to ensure that every bit of information is being held and is secured to avoid problems down the line. Furthermore, it should be that you must be able to have it accessed easily regardless the time as well. By choosing a dependable accounting system training like Xero, you should be certain that your data is safe.
Time also is something that you will have cut significantly by choosing the right accounting online system training as this provides you with the benefit of filling out employee payroll with ease. This alone assures that the time needed to get things done will be cut significantly.
Landing on the right bookkeepers and accounting system training also is a great way for you to be certain that your cash flow is being managed in the most efficient means possible, which, should also help you in terms of saving money. Remember that these software and system training assures that things will rather be easier when it comes to determining incentives for employees. Explore more wisdom about bookkeeping https://en.wikipedia.org/wiki/Category:Bookkeepers.


This Altamonte Springs one-story offers a den and a two-car garage. Upgraded features include fresh interior and exterior paint, new carpet in select room, and a new roof. This home is part of the Robin Hill HOA.


text:
State recognition
Bachelor Islamic Theology NL
Master Islamic Spiritual Care NL
English Master Degree Islamic Spiritual Care (ENG)
Qoran recitation
IUR Press Publications
Academic Journal JRISS
Rumi Islamic art center
Code of Conduct and Regulations
International Office Team
Information for incoming students
Outgoing Erasmus+ students application form
Incoming students activities & courses
Erasmus+ Student Charter
Disclaimer en Logo
Equality and Non-discrimination
Examination Board & the Commission for Board of the Exams
Organization of the IUR
Learning & Grant Agreement
Home News Islamic university education in Russia and its surrounding areas
Islamic university education in Russia and its surrounding areas
iuradmin 8 December 2015 21 December 2015 News
The IUR Rector Prof. Akgunduz has presented a paper in International Conference on: Islamic university education in Russia and its surrounding areas and signed a cooperation agreement with Tatar State University of Humanities and Education
(Russian Islamic University, Kazan, Tatarstan: 27-30 September 2009)
The Russian Federation, like a great number of Eastern and Central European countries, is characterized by the existence of original Muslim communities whose roots stretch deep in history and who have the same racial and linguistic features as the populations of the area. Unlike West European countries, the presence of Muslims in these areas is not a new phenomenon brought about by what is currently known as international migration which was the inevitable result of colonization and industrial revolution and their implications on the demographic movement during the last century. Indeed, these transformations have substantially contributed to reshaping the demographic structure in European countries which have all turned into multicultural societies. This situation pushed these countries to devise plans and strategies aimed at dissolving Muslim communities at the social, cultural and educational levels and integrate them, willingly or unwillingly, in the existing systems together with their secular trends and positivist philosophy. This led to the emergence of opposition tendencies to the policies of exclusion and marginalization, and the upsurge of strong sentiments towards cultural specificities and the right to difference. These tendencies did not, however, entail a preference for introversion or isolation from the surrounding environment.
In consideration of the leading role and civilizational mission that educational institutions in Central and Eastern Europe have been performing, particularly in the Russian Federation; and believing in the necessity to upgrade the level of higher education in this area and support its civilizational mission, the General Secretariat of the Federation of the Universities of the Islamic World, the Islamic Educational, Scientific and Cultural Organization ISESCO- and the Russian Islamic University will hold the international conference on Islamic university education in Russia and its surrounding areas.
Prof. Dr. Ahmed Akgunduz has presented a paper under the title "The Role of Higher Education on Muslim Minorities in European Countries" and focused on that through academic education and research, the IUR aims at contributing to the concretization of the following anthological synthesis: "Live as a Muslim and as a responsible citizen of the Dutch society."
Prof. Akgunduz has signed a cooperation agreement with Tatar State University of Humanities and Education
The IUR has been part of the 7th Doha Interfaith Conference
12 − three =
U kunt uw zakat, aalmoezen, donaties en giften over maken via Paypal
Choose a language Nederlands English
LECTURE RECTOR HARTFORD SEMINARY
Symposium Islamic Reformation and Tajdid
Call for Papers Workshop: Modernity, Reform and Tajdid (Renovation)
About Sheikh-al-Islam Ebussuʻûd Fetawa
Aanmelden voor IUR News Letter
Nieuws Letter in Dutch
Nieuws Letter in English
Copyright © 2017 - Islamic University of Applied Sciences Rotterdam
Islamic University of Applied Sciences Rotterdam IT Department